Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Renal Associates LLC — Columbus, Georgia (7.3 mi)
· Sponsor: CSL Behring
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
AllerVie Clinical Research — Columbus, Georgia (7.3 mi)
· Sponsor: Biometry Inc
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: vTv Therapeutics
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Phase 2
Interventional 300 participants sought
Columbus Memory Center — Columbus, Georgia (7.3 mi)
· Sponsor: Lighthouse Pharmaceuticals, Inc.
Study of BHV-1300 in Graves' Disease
Graves Disease
Phase 1
Interventional 15 participants sought
Site-104 — Columbus, Georgia (7.3 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Idiopathic Short Stature
Phase 2
Interventional 100 participants sought
Centricity Research — Columbus, Georgia (7.3 mi)
· Sponsor: BioMarin Pharmaceutical
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus, T2DM
Phase 2
Interventional 180 participants sought
Centricity Research IRT - DBA IACT Health Columbus Piedmont — Columbus, Georgia (7.3 mi)
· Sponsor: Hanmi Pharmaceutical Company Limited
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Columbus, Georgia (7.3 mi)
· Sponsor: Alnylam Pharmaceuticals
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Locally Advanced Pancreatic Cancer
Phase 3
Interventional 190 participants sought
Piedmont-Columbus Regional - John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: RenovoRx
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Phase 3
Interventional 55 participants sought
Centricity Research Columbus Endocrinology — Columbus, Georgia (7.3 mi)
· Sponsor: Eli Lilly and Company
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Hoffmann-La Roche
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Phase 3
Interventional 705 participants sought
Clinical Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Centricity Research, Endocrine Consultants PC — Columbus, Georgia (7.3 mi)
· Sponsor: Biomea Fusion Inc.
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Phase 3
Interventional 32,500 participants sought
Centricity Research Columbus Georgia Multispecialty — Columbus, Georgia (7.3 mi)
· Sponsor: Pfizer
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 500 participants sought
Local Institution - 2134 — Columbus, Georgia (7.3 mi)
· Sponsor: Turning Point Therapeutics, Inc.
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Hypertension, Uncontrolled Hypertension
Phase 2
Interventional 240 participants sought
Vanda Investigative Site — Columbus, Georgia (7.3 mi)
· Sponsor: Vanda Pharmaceuticals
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion
N/A
Interventional 126 participants sought
Hughston Foundation Inc — Columbus, Georgia (7.3 mi)
· Sponsor: Kuros Biosurgery AG
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 500 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb